REQUEST A DEMO
Total
USD $0.00
Search more companies

Ligula Pharma d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Ligula Pharma d.o.o. Profile Updated: July 21, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Ligula Pharma d.o.o. is based in Croatia, with the head office in Zagreb. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. Ligula Pharma d.o.o. was incorporated on July 23, 2026. 4 (2025) employees currently work for Ligula Pharma d.o.o.. From the latest financial highlights, Ligula Pharma d.o.o. reported a net sales revenue increase of 51.52% in 2025. During that time, Ligula Pharma d.o.o.’s total assets grew by 74.67%. The net profit margin of Ligula Pharma d.o.o. increased by 8.01% in 2025.

Headquarters
Trg Drage Iblera 7 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Ligula Pharma d.o.o. report to view the information.

Website: http://www.ligulapharma.hr

Basic Information
Total Employees:
Purchase the Ligula Pharma d.o.o. report to view the information.
Financial Auditors:
Purchase the Ligula Pharma d.o.o. report to view the information.
Incorporation Date:
July 23, 2026
Key Executives
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Ligula Pharma d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
51.52%
Total Operating Revenue
51.52%
Operating Profit
80.23%
EBITDA
78.33%
Net Profit/Loss for the Period
112.65%
Total Assets
74.67%
Total Equity
49.98%
Operating Profit Margin
4.59%
Net Profit Margin
8.01%
Return on Equity (ROE)
11.17%
Quick Ratio
-10.64%
Cash Ratio
-1.76%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?